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A simple and powerful method for the determination of labeling sites on oligodeoxynucleo-
tides (ODN) has been developed. The method is based on the finding that nuclease P1 (NP1)
digestions of label-containing ODNs produce site-specific products: 59-labeled ODNs produce
label–nucleotide (L–N); 39-labeled ODN produces phosphorylated label (pL); and a label in
between the ODN termini produces pL–N. Mass spectrometry spectra of these products from
the digestion mixture can be easily utilized for structural verification of labeled ODNs such as
DNA probes. We also developed a method for the determination of the labeling sites of ODNs
with unknown label structures. In this method, NP1 digestion products generate site-specific
fragmentation patterns upon collision-induced dissociation. These patterns can be easily
recognized and used for the identification of labeling sites of ODNs with unknown label
structures. When an ODN is internally labeled, phosphodiesterase digestion may be used to
determine the exact labeling site (sequence location). It was demonstrated that these methods
can be applied for ODNs with single or multiple labels, and for ODNs with the same or
different labels within an ODN. (J Am Soc Mass Spectrom 1998, 9, 660–667) © 1998
American Society for Mass Spectrometry
The diverse modifications of oligodeoxynucleoti-des (ODN) for diagnostic research present uniquechallenges to the analytical chemist. These mod-
ifications often include the incorporation of chemical
labels; e.g., phosphate, amine, thiol, biotin or fluoros-
cein, at the 59 or 39 terminus of a DNA probe (labeled
ODN), for the purpose of detection, coupling, or immo-
bilization [1]. Although the synthesis of ODNs has
become routine in many laboratories, the analytical
methods have been limited to chromatographic and
electrophoretic techniques that usually provide purity
information only. Further characterization of DNA
probes in the diagnostics industry includes base com-
position analysis [2]. This technique is based on high-
performance liquid chromatography (HPLC) analysis
of the enzymatic digestion products, however, the re-
sults usually cannot specify label location(s), nor can
they distinguish different labels definitely.
The introduction of electrospray (ES) [3] and matrix-
assisted laser desorption/ionization (MALDI) [4] mass
spectrometry (MS) in the late 1980s made it possible to
analyze large ODNs. These new mass spectrometry
techniques have become powerful tools for the deter-
mination of both accurate molecular weight (MW) and
chemical structures of ODNs [5–8]. Characterization of
ODNs often includes the determination/verification of
base sequences and the identification of base modifica-
tions. Sequence analysis can be achieved by direct mass
spectrometry method using gas-phase fragmentation of
the pseudo-molecular ions of ODNs such as desorp-
tion/ionization induced fragmentation, tandem mass
spectrometry, nozzle–skimmer, and photodissociation
[5]. Sequencing ODNs can also be achieved by indirect
methods by mass spectrometry analysis of enzymatic
digestion products of the ODNs [5]. Exonucleases (59-
or 39-phosphodiesterase) have been used the most for
sequence analysis [9]; base-specific endonuclease such
as RNase T1 has been used for sequence location of
post-transcriptional modifications of RNAs [10]; an acid
hydrolysis approach [11] was also proposed to charac-
terize ODNs, but no application has been reported. For
structural analyses of modified DNAs with modified
bases or DNA-carcinogen adducts, there have been
extensive studies using MS/MS analysis of enzymatic
digestion products [12–15]. Direct characterization of
ODNs with modified bases using MS/MS or desorp-
tion/ionization induced fragmentation has also been
reported [16–21].
Although regular and base-modified ODNs have
been studied by mass spectrometry techniques, charac-
terization of the labeled ODNs, with labels incorporated
into ODN backbone by regular phosphodiester bonds
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through the phosphoramidite approach, has not been
reported. We report here two mass spectrometry meth-
ods for the characterization of such labeled ODNs.
Enzymatic digestion products of ODNs are analyzed
using ionspray mass spectrometry (MS) and tandem
mass spectrometry (MS/MS). Results from these exper-
iments permit the determination/verification of ODN
labeling sites and the verification of label structures.
Experimental
Mass Spectrometry
An API III1triple quadrupole mass spectrometer
(Sciex, Thornhill, Ontario, Canada) was used for all
experiments. The instrument has a mass-to-charge ratio
range of 0–2400 and is fitted with a pneumatically
assisted electrospray (ionspray) interface. Multiply
charged ODN ions were generated by spraying the
solution through a stainless steel capillary held at
24000 V. The sample solution was delivered to the
sprayer by a syringe infusion pump (model 22, Harvard
Apparatus, South Natick, MA) through a fused silica
capillary of 100-mm inner diameter. The carrier solvent
was 1:1 acetonitrile/water with 2 mM NH4HCO3. The
carrier flow rate was set at 20 mL/min for sample
introduction. ODN samples were dissolved in or di-
luted with 1:1 ACN/20 mM NH4HCO3. The potential
on the sampling orifice was set at 35 V during calibra-
tion and was changed to 265 V for DNA signal en-
hancement. The instrument mass-to-change ratio scale
was calibrated with the singly charged ammonium
adduct ions of poly(propylene glycols) (PPGs) under
unit resolution (50% valley definition). For collision-
induced dissociation (CID) tandem mass spectrometry
(MS/MS), collision gas thickness is set at 250 (2.5 3 1014
Ar atoms/cm2). Nebulization and curtain gases are set
at 0.6 L/min.
Chemicals and Enzymatic Digestions
Chemicals. All ODNs were synthesized in-house on a
Applied Biosystems 380B DNA synthesizer using 2-cy-
anoethylphosphoramidite coupling chemistry and were
purified by reverse-phase high performance liquid
chromatography (RP-HPLC). Phosphoramidites, in-
cluding biotin and fluoroscein phosphoramidites were
purchased from Clontech Laboratories (Palo Alto, CA)
or prepared in-house. Bacterial alkaline phosphatase
(BAP), phosphodiesterases (PDEs), nuclease P1 (NP1),
and nuclease S1 (NS1) were purchased from Boerhinger
Mannheim Biochemicals (Indianapolis, IN). All solvents
are HPLC grade or better and were purchased from EM
Science (Gibbstown, NJ).
Purification of enzymes. To ensure best performance of
enzymes and mass spectrometry analysis, all enzymes
were purified with Microcon 50 microconcentrators
(Amicon, Beverly, MA). For snake venom phosphodi-
esterase (39-PDE), which was suspended in concen-
trated (NH4)2SO4 when purchased, 40 mL was centri-
fuged to pellet the enzyme. The pellet was re-dissolved
in 80 mL distilled water, and the solution was loaded to
a Microcon 50. The filters were washed three times with
80 mL of distilled water and reconstituted in distilled
H2O to a desired concentration. For calf spleen phos-
phodiesterase (59-PDE), which was dissolved in 50%
glycerol, a similar procedure was used except that no
centrifugation was performed. BAP was purified the
same way as 39-PDE. Only NP1 was dissolved in
distilled water without further purification.
39-PDE digestion. Ten mL of 1/1 acetonitrile/2 mM
NH4HCO3 and 1–2 mL of 2 units/mL of the enzyme
were added to 0.02 OD units of ODN (;100 pmol)
sample. The mixture was incubated in a 37 °C water
bath for 30 min.
59-PDE digestion. Ten mL of 20 mM HCOONH4 (pH
6.6) and 1–2 mL of 2 units/mL of the enzyme were
added to 0.02 OD units of ODN sample. The mixture
was incubated in a 37 °C water bath for 30 min.
NP1 digestion. Ten mL of 20 mM HCOONH4 aqueous
solution and 0.1 unit of NP1 were added to 0.02 OD
units of ODN sample. The reaction mixture was incu-
bated in a 50 °C water bath for 20 min.
NS1 digestion. Ten mL of 20 mM HCOONH4 aqueous
solution and 1 unit NS1 were added to 0.02 OD units of
ODN sample. The reaction mixture was incubated in a
50 °C water bath for 20 min.
BAP digestion. Ten mL of 10 mM NH4HCO3 (or 1:1
ACN/H2O12 mM NH4HCO3) and 0.2 units of BAP
were added to 0.02 OD units of DNA sample. The
mixture was incubated for 20 min in a 37 °C water bath
before mass spectrometry analysis.
Results and Discussion
Mass Spectrometry Analysis of NP1 Digestion
Products for the Determination of ODN Labeling
Sites with Known Label Structures
DNA probes are frequently labeled at various locations
along their ODN backbones. Such labels include biotin,
fluoroscein, rhodamine, dansyl, carbazole, and ada-
mantane, that are incorporated into ODN backbone via
phosphoramidite chemistry in automated DNA synthe-
sis. Because biotin (B) is among the most widely used
nonradioactive DNA labels that can be detected by a
secondary detection system such as a biotin–enzyme–
conjugated-streptavidin system [16], five biotin-con-
taining model ODNs were synthesized and studied.
These model ODNs contain the same base sequence and
differ only in the locations of their biotin moiety, as
shown in Table 1. ODNs I, III, and II are of the same
MWs, with biotin at 59-terminus, 39-terminus, and in
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between the termini, respectively. ODN IV contains a
biotin at the 39-terminus and an additional short uni-
versal linker [OH–(CH2)2–OH] on the biotin moiety
(Bl). ODN V contains three biotins, each located at the
same site as in one of the above three ODNs (I, II, and
IV). The structures of these probes are shown in Figure
1.
Various nucleases have been used to digest these
model ODNs and the digestion products were analyzed
by electrospray mass spectrometry. These enzymes
included NP1, NS1, 39-PDE, and 59-PDE. Digestion
products from using all of these enzymes provided
some information about the labeling sites, with NP1
giving the most complete information and the highest
digestion efficiency. NS1 digestion provided similar
information, but with slower digestion rate and rela-
tively poor digestion efficiency. PDE digestions pro-
vided some information, but did not work in many
cases.
PDE digestions are known to require a free 39-
terminus (39-PDE) or 59-terminus (59-PDE). Using the
model ODNs, it was found that such digestions stopped
at one base away from the label from the direction of
digestion. As a result, mass spectrometry analysis of
PDE digestion products provided only limited informa-
tion of labeling sites, as shown in Table 2. With 39-PDE,
a biotin-labeled nucleotide B–C was produced follow-
ing the digestion of ODN I. An ion corresponding to
B–C was observed by mass spectrometry. With ODN II,
59-CGT ATG AGT B G was generated following the
digestion, and the detection of such a shortened ODN
indicated that there is at least one label in the middle of
the ODN backbone. For ODN III, IV, and V, no 39-PDE
digestion products were found, indicating a label at the
39-terminus. When 59-PDE digestions were performed
for the five above mentioned compounds, more infor-
mation was obtained, as shown in Table 2. However, no
information was obtained when both termini are la-
beled (DNA V).
Nuclease P1 digestion, on the other hand, provides
much more information about labeling sites, regardless
of the locations of the labels. Figure 2a–e shows the
mass spectrometry spectra of NP1 digestion products of
the five model oligonucleotides, which are also shown
in Table 2. In the low mass-to-charge ratio range of all
mass spectra, four major ions at m/z 306.2, 321.2,
330.2, and 346.2, are always observed. These ions
correspond to deprotonated molecules of the four
nucleosides 59-monophosphate (59-NMP), which are
standard NP1 digestion products of regular ODNs. In
addition to these standard ions, site-specific ions corre-
sponding to the three biotin locations in the five model
ODNs (Figure 2a–e) are observed.
With the biotin label at the 59-terminus (ODN I), the
characteristic ion observed is m/z 661.2 (Figure 2a).
MW calculation of fragments at all potential cleavage
sites indicates that this ion corresponds to deprotonated
biotin–nucleotide (B–N). Similarly, a different ion at
m/z 781.2 (Figure 2b) is observed for the ODN with a
biotin in-between the termini (ODN II). Out of the same
consideration, the digestion product is proposed to be a
phosphorylated biotin–nucleotide (pB–N), very similar
to the product from 59-biotin labeled ODN. With the
biotin label at the 39-terminus (ODN III), the character-
istic ion is found to be m/z 452.2 (Figure 2c). The
corresponding digestion product is proposed to be pB,
a phosphorylated biotin moiety. When a universal
linker is attached to the 39-terminal biotin (ODN IV), the
characteristic ion is found to be m/z 576.2 (Figure 2d).
The corresponding digestion product is proposed to be
pBl, a phosphorylated biotin moiety with the linker
attached. A comparison between NP1 digestion of ODN
III & IV indicates that the phosphodiester bond between
Figure 1. The structures of labeled ODNs: (1) 59-biotinylated
ODNs; (2) ODNs with biotin in-between termini; (3) 39-biotinyl-
ated ODNs with (x 5 1) and without (x 5 0) the universal linker;
(4) biotin moiety in labeled ODNs. Squiggly lines in the structures
represent the extension sites of ODN backbone structures.
Table 1. Model ODNs containing biotin moieties
Sequence ODN #
59-B CGT ATG AGT GAT TCC TCC-39 I
59-CGT ATG AGT B GAT TCC TCC-39 II
59-CGT ATG AGT GAT TCC TCC B-39 III
59-CGT ATG AGT GAT TCC TCC Bl-39 IV
59-B CGT ATG AGT B GAT TCC TCC Bl-39 V
Table 2. Proposed digestion products as observed by mass spectrometry
Enzyme\ODN ODN I ODN II ODN III/IV ODN V
59-PDE None T B GAT TCC TCC-39 C–B/C–Bl None
39-PDE B–C 59-CGT ATG AGT B G None None
NP1 B–C pB–G C–B/C–Bl B–C & pB–G & C–Bl
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the biotin moiety and the universal linker cannot be
cleaved by the NP1.
The above results indicate that NP1 digestion of
ODNs with biotin(s) at different sites generates site-
specific products. ODNs with biotins at the 59-terminus,
39-terminus, and in between form B–N, pB, and pB–N,
respectively, and the site-specific ions from these diges-
tion products on a mass spectrum can be used to
determine the location(s) of biotin along the ODN
backbone.
To test the method on more complex samples, ODN
V containing biotins at all three locations was digested
using NP1 and mass spectrometry analyzed. All of the
three characteristic ions were observed (Figure 2e),
showing a biotin moiety at all three different sites. This
result indicated that this simple method can be used to
identify multiple labels on an ODN. In a single diges-
tion, the biotin labels at all three different locations were
identified due to their site-specific products, demon-
strating the effectiveness of this simple technique.
Figure 2. Mass spectrometry spectra of NP1 digestion products of five model ODNs: (a) 59-B CGT
ATG AGT GAT TCC TCC-39; (b) 59-CGT ATG AGT B GAT TCC TCC-39; (c) 59-CGT ATG AGT GAT
TCC TCC B-39; (d) 59-CGT ATG AGT GAT TCC TCC Bl-39; (e) 59-B CGT ATG AGT B GAT TCC TCC
Bl-39.
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The structures of these products, as shown in Figure
3, were characterized and confirmed by CID MS/MS.
The CID-MS/MS spectra are shown in Figure 4a–d. The
product ions observed are consistent with the proposed
structures for these products.
Based on the above observations, the final site-
specific products from a NP1 digestion of an ODN can
be easily predicted when its sequence and label struc-
ture are provided. For ODNs with the same biotin label
structures as in the five model ODNs, biotin locations
can be obtained from NP1 digestion and mass spec-
trometry analysis. Table 3 shows the characteristic ions
from such ODNs. It should be pointed out there is no
confusion in assigning the locations of biotin labels
because the structures of these digestion products are so
distinctively different: B–N, pB–N, and pB/pBl. For
instance, the heaviest B–N ion is at m/z 701.2 (B–G)
and the lightest pB–N is at m/z 741.2 (pB–C).
The universality of the method was also studied
using other common labels (L) such as fluorescein,
dansyl, carbazole, and adamantane, that are joined to
the ODNs by regular phosphodiester bonds through
the phosphoramidite approach. It was found that NP1
digestion of ODNs containing these labels generated
products with the same patterns as those for biotinyl-
ated ODNs; and the digestion products are shown in
Table 4.
When an ODN is modified by distinct labels, all the
labels can be identified effectively with this method in a
single digestion. Figure 5 shows the mass spectrometry
spectrum of the NP1 digestion products of a DNA
probe containing both biotin and carbazole. The loca-
tions of both labels were clearly identified in a single
spectrum.
With labeled homo oligonucleotides, caution must
be taken when interpreting the mass spectrometry
spectrum. This is clearly demonstrated with 59-fluoros-
cein-A25 (Figure 6a), an additional peak at m/z 661.2
was observed; and it can be easily misinterpreted as a
peak derived from a different label. However, the
CID-MS/MS spectrum (Figure 6b) of the ion indicates
that it corresponds to cluster ions (nM–H)2, with n 5 2
and M 5 AMP (adenosine 59-monophosphate). The
cluster formation is also evidenced by the presence of a
very intense peak of 59-AMP at m/z 330.2, absence of
other nucleoside 59-monophosphates (59-NMP), and the
cluster ions at m/z 992.3 (n 5 3). The formation of the
cluster ions is assumed to be the result of the relatively
high concentration of 59-AMP in the digestion mixture.
As has been demonstrated above, this enzymatic
method followed by mass spectrometry analysis can be
readily applied for structure verification of labeled
ODNs such as DNA probes. This makes it a powerful
technique for quality control of labeled ODNs.
MS/MS Analysis of NP1 Digestion Products for
the Determination of ODN Labeling Sites with
Unknown Label Structures
When ODNs contain unknown labels that vary in label
structure and linker length, it is difficult to apply the
above discussed method for the identification of label-
ing sites based on MW determination of the digestion
products. To solve this problem, we studied the above
NP1 digestion products using CID-MS/MS. The
MS/MS spectra of these digestion products provide
distinctive features that can be applied for the determi-
nation of the locations of labels on ODNs.
For the digestion products (B–C) from the 59-labeled
ODN I, the MS/MS spectrum (Figure 4a) shows the
following major peaks: (M–H–base)2 ion (m/z 550)
from loss of the base (cytosine) and (M–H–nucleoside)2
ion (m/z 452) from loss of the nucleoside. Loss of
59-NMP to produce (M–H–NMP)2 ions (m/z 354)
cannot be detected presumably because the biotin moi-
ety does not contain functional groups that can stabilize
negative charges effectively.
With pB–G, a digestion product from ODN II & V,
major fragment ions (Figure 4b) are totally different
from those observed for the dephosphorylated analog
(Figure 4a). In fact, the major fragment ions for B–C,
(M–H–base)2 and (M–H–nucleoside)2, are no longer
major ions. Instead, three other ions become dominant:
(M–H–NMP)2 ions from loss of 59-NMP (m/z 434.2),
(M–H–H3PO4)
2 ions from loss of H3PO4 (m/z 683)
from the molecular ion (M–H)2, and (59-NMP–H)2
from loss of the label moiety (m/z 346.0). To find out
if the MS/MS spectral difference between B–C and
pB–G is because of the base difference, pB–G was
dephosphorylated by bacterial alkaline phosphatase
(BAP). The resulting product B–G was subjected to
CID-MS/MS (Figure 4c) and the same pattern as that
for B–C (Figure 4a) was observed. Therefore, the dra-
matic spectral difference between B–C and pB–G (Fig-
ure 4a, b) is not the result of base difference but the
consequence of phosphorylation. The additional phos-
phate group adds two more favorable deprotonation
sites from which different fragment ions are formed.
Figure 3. Chemical structures of NP1 digestion products of the
five model ODNs: (a) 59-NMP; (b) B–C; (c) pB–G; (d) pBl; (e) pB;
(f) the structure of the biotin moiety.
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Figure 4. CID-MS/MS spectra of NP1 digestion products of the model ODNs: (a) m/z 661.2 of B–C;
(b) m/z 781.2 of pB–G; (c) m/z 701.2 of B–G; (d) m/z 452 of pB; (e) m/z 576 of pBl. L in (e)
designates the linker HOCH2CH2OH.
Table 3. Biotin locations and the end NP1 digestion products observed by mass spectrometr
59-Biotin
Products in general Biotin–nucleotide (B–N)
Possible products B–C B–T B–A B–G
Ions [m/z of (M–H)2] 661.2 676.2 685.2 701.2
Biotin in between the
termini
Products in general pB–N
Possible products pB–C pB–T pB–A pB–G
Ions [m/z of (M–H)2] 741.2 756.2 765.2 781.2
39-Biotin (or 39-biotin-
linker)
Product pB or pBl
Ions [m/z of (M–H)2] 452.2 for pB (or 576.2 for pBl)
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Comparison of the above MS/MS spectra clearly
shows that major fragment ions for B–N are minor for
pB–N, and vice versa. This is clearly shown in Table 5.
The MS/MS spectral difference is presumably because
of the fact that negative charges for all the ions formed
reside favorably on the phosphate group or the phos-
phodiester linkage because of their high gas phase
acidities, and that charges at other sites are not as stable.
This is especially true when the label moiety such as
biotin/fluoroscein contains no site that can be deproto-
nated as easily as the phosphate group and the phos-
phodiester linkage.
With pB, a NP1 digestion product of the 39-labeled
ODN III, a dominant fragment ion at m/z 79 (PO3
2) is
found (Figure 4d). All other ions become insignificant.
For the pBl, dominant ions include phosphate group
and linker related ions (Figure 4e): PO3
2 ions at m/z 79,
H2PO4
2 ions at m/z 97, deprotonated phosphorylated
linker (pL) ions at m/z 141, loss of pL at m/z 434. The
dominance of these ions (m/z 79, m/z 97) and the
absence of nucleotide bases can be used as the indica-
tion for labels at the 39-terminus.
Clearly, the MS/MS spectra of the digestion prod-
ucts from labeled ODNs have shown site-specific frag-
mentation patterns, as summarized in Table 5. These
patterns can be readily used to determine if a digestion
product under investigation contains a label at the 59- or
39-terminus or in between the two termini. When ODN
samples contain unknown labels, the MS/MS spectra of
the digestion products can be obtained first. If a site-
specific digestion product (M) contains a nucleotide
base as in the case of ODNs with labels at the 59-
terminus (L–N) or in between the termini (pL–N), the
base bonded to the label can be readily identified by the
presence of the deprotonated base (purines and pyrimi-
Figure 5. MS spectrum of NP1 digestion products of an ODNs
labeled with carbazole (Cb) and biotin. “Bl” stands for biotin is
attached to a 39-terminal universal linker (see text for details).
Figure 6. Mass spectrometry spectrum of fluorescein (Fl)-labeled homo ODN Fl–A25; (b) CID-
MS/MS spectrum of m/z 661.2 of 59-AMP dimer.
Table 4. NP1 digestion products of ODN containing
phosphodiester-bond linked labels
Labeling sites Digestion products
59-Label L–C, L–T, L–A, L–G
Label in between the termini pL–C, pL–T, pL–A, pL–G
39-Label pL
Table 5. CID-MS/MS ion abundance of digestion products
Fragment ionsa
Ion abundanceb
B–G pB–G pB pBl
PO3
2 (m/z 79) m m hh h
(Base–H)2 (m/z 110, 125, 134, 150) m m
(NMP–H)2 (m/z 306, 321, 330, 346) l h
(M–H–H3PO4)
2 l h
(M–H–base)2 (M–112/127/136/152) h l
(M–H–nucleoside)2 h l
(M–H–NMP)2 l h
Phosphorylated linker [(pL–H)2] h
(M–H–pL)2 h
H2PO4
2 (m/z 97) l m w h
aAbbreviations: base—nucleoside base; NMP—nucleoside 59-mono-
phosphate; nucleoside—dehydrated nucleosides with unknown struc-
tures (refer to spectra).
bAbundance: l—low, m—medium, h—high, hh—dominant; collision
energy 5 30 eV.
666 WU ET AL. J Am Soc Mass Spectrom 1998, 9, 660–667
dines) at m/z 110, 125, 134, and 150 for C, T, A, & G,
respectively. The presence of the bases can often be
verified by the presence of (M–H–base)2 or (M–H–
NMP)2. In contrast, absence of all these ions from
MS/MS spectra of the site-specific products is an indi-
cation that the label is at the 39-terminus. High abun-
dance of (NMP–H)2 ion or (M–H–H3PO4)
2 ion is an
indication that a label is in between the termini. High
abundance of (M–H–nucleoside)2 and (M–H–base)2 is
an indication that a label is at the 59-terminus. Domi-
nance of m/z 79 and absence of nucleotide bases
indicates a label at the 39-terminus. It should be pointed
out that the relative intensity (l, m, or h) should be
compared within one spectrum and that any conclusion
based on a single ion should be confirmed by other ions.
When ODNs contain other labels such as fluorescein
and carbazole, the same fragmentation and relative
abundance patterns have been observed (data not
shown). Therefore, the fragmentation patterns of dep-
rotonated digestion products from CID-MS/MS spectra
can be used to determine the labeling sites on unknown
ODNs. In practice, major ions at mass-to-charge ratio
values above 400 should be analyzed by MS/MS. For
39-labeled ODNs, dominant ions are m/z 79, 97 and
ions from linker or loss of linker. For 59-labeled ODNs,
(M–H–base)2 and (M–H–nucleoside)2 is much more
abundant than (NMP–H)2, (M–H–H3PO4)
2, and (M–
H–NMP)2. If the observed abundance pattern is re-
versed, the labels must be in-between the two termini.
Conclusions
We have developed a simple and powerful method for
locating labeling sites on ODNs. The method is based
on the findings that NP1 digestion of label-containing
ODNs produces site-specific products: a 59-labeled
ODN produces an ion corresponding to label–nucle-
otide (L–N); a 39-labeled ODN produces an ion of
phosphorylated label (pL); and a label in between the
ODN termini produces an ion of pL–N. These digestion
products can be readily identified by mass spectrome-
try to determine the labeling sites, and the chemical
structures of the labels can be verified by the CID-
MS/MS spectra of the digestion products. The effective-
ness and simplicity of this method make it a valuable
tool for the characterization of labeled ODNs such as
DNA probes.
We also developed a method for the determination
of labeling sites of ODNs with unknown label struc-
tures, based on the CID-MS/MS spectra of NP1 diges-
tion products of the samples. CID-MS/MS of NP1
digestion products generates site-specific fragmentation
patterns. These patterns can be easily recognized and
used for the identification of ODN labeling sites with
unknown label structures. It has been demonstrated
here that both methods can be applied for ODNs with
single or multiple modifications, and for ODNs with the
same or different labels within an ODN.
The limitations of the methods described in this
work should be pointed out. The methods with NP1
digestion can determine the exact labeling sites (se-
quence locations) when a label is at 59- or 39-terminus of
an ODN. When a label is incorporated in between the
termini of an ODN, however, the combination of NP1
digestion and ES-MS or ES-MS/SM can only determine
that the ODN is internally labeled and to which of the
four nucleotides the label is attached, but it cannot
determine the exact labeling site (sequence location). In
such cases, if one of the termini such as 39-terminus is
free, 39-PDE digestion can be performed to determine
the exact labeling site, as data shown in Table 2. If both
termini are labeled, the exact labeling site of an internal
label cannot be determined by mass spectrometry or
MS/MS analysis of the NP1 digestion products. In such
a case, CID-MS/MS analysis of the original ODN may
provide the labeling-site information of the internal
label if the ODN is relatively small (ODNs of 15 bases
long may be the practical limit). For larger ODNs, new
methods have to be developed.
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